Aminophospholipid Asymmetry: A Matter of Life and Death

Annual Review of Physiology

Volumn 65, Issue , 2003, Pages 701-734

  Balasubramanian, Krishnakumar ^a   Schroit, Alan J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Phagocytosis; Phosphatidylethanolamine; Phosphatidylserine; Receptors

Indexed keywords

ADENOSINE TRIPHOSPHATASE (MAGNESIUM); AMINOPHOSPHOLIPID; BETA2 GLYCOPROTEIN 1; CALRETICULIN; CD14 ANTIGEN; COMPLEMENT RECEPTOR; MEMBRANE LIPID; MULTIDRUG RESISTANCE PROTEIN; SCAVENGER RECEPTOR; SCRAMBLASE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE;

APOPTOSIS; BIOGENESIS; BLOOD CLOTTING; CELL CYCLE; CELL MEMBRANE; CELL SURFACE; CELL TRANSPORT; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; LIFESPAN; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR VASCULARIZATION; WOUND HEALING; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL MEMBRANE; HUMANS; PHAGOCYTOSIS; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLSERINES;

EID: 0037938686     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.65.092101.142459     Document Type: Review

References (256)

1. Verkleij AJ, Post JA. 2000. Membrane phospholipid asymmetry and signal transduction. J. Membr. Biol. 178:1-10
2. Daleke DL, Huestis WH. 1989. Erythrocyte morphology reflects the transbilayer distribution of incorporated phospholipids. J. Cell Biol. 108:1375-85
3. Zwaal RF, Schroit AJ. 1997. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89:1121-32
4. Solum NO. 1999. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler. Thromb. Vasc. Biol. 19:2841-46
5. Henson PM, Bratton DL, Fadok VA. 2001. Apoptotic cell removal. Curr. Biol. 11:R795-805
6. Payrastre B, Missy K, Giuriato S, Bodin S, Plantavid M, Gratacap M. 2001. Phosphoinositides: key players in cell signalling, in time and space. Cell. Signal. 13:377-87
7. Spiegel S, Foster D, Kolesnick R. 1996. Signal transduction through lipid second messengers. Curr. Opin. Cell Biol. 8:159-67
8. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. 2001. Lysophospholipids - receptor revelations. Science 294:1875-78
9. D'Hondt K, Heese-Peck A, Riezman H. 2000. Protein and lipid requirements for endocytosis. Annu. Rev. Genet. 34:255-95
10. Rothman JE, Lenard J. 1977. Membrane asymmetry. Science 195:743-53
11. Pomorski T, Hrafnsdottir S, Devaux PF, van Meer G. 2001. Lipid distribution and transport across cellular membranes. Semin. Cell Dev. Biol. 12:139-48
12. Raz A, Bucana C, Fogler WE, Poste G, Fidler IJ. 1981. Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res. 41:487-94
13. Tanaka Y, Schroit AJ. 1983. Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells. Recognition by autologous macrophages. J. Biol. Chem. 258:11335-43
14. Schroit AJ, Madsen JW, Tanaka Y. 1985. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J. Biol. Chem. 260:5131-38
15. Vance JE, Shiao YJ. 1996. Intracellular trafficking of phospholipids: import of phosphatidylserine into mitochondria. Anticancer Res. 16:1333-39
16. Voelker DR. 2000. Interorganelle transport of aminoglycerophospholipids. Biochim. Biophys. Acta 1486:97-107
17. Kuge O, Nishijima M, Akamatsu Y. 1986. Phosphatidylserine biosynthesis in cultured Chinese hamster ovary cells. III. Genetic evidence for utilization of phosphatidylcholine and phosphatidylethanolamine as precursors. J. Biol. Chem. 261:5795-98
18. Vance JE, Vance DE. 1988. Does rat liver Golgi have the capacity to synthesize phospholipids for lipoprotein secretion? J. Biol. Chem. 263:5898-909
19. Voelker DR. 1989. Phosphatidylserine translocation to the mitochondrion is an ATP-dependent process in permeabilized animal cells. Proc. Natl. Acad. Sci. USA 86:9921-25
20. Sprong H, van der SP, van Meer G. 2001. How proteins move lipids and lipids move proteins. Nat. Rev. Mol. Cell Biol. 2:504-13
21. Seigneuret M, Devaux PF. 1984. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc. Natl. Acad. Sci. USA 81:3751-55
22. Kuypers F, Linde-Sibenius-Trip M, Roelofsen B, Tanner MJ, Anstee DJ, Op den Kamp JA. 1984. Rh null human erythrocytes have an abnormal membrane phospholipid organization. Biochem. J. 221: 931-34
23. Schroit AJ, Bloy C, Connor J, Cartron JP. 1990. Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry. Biochemistry 29:10303-6
24. Le van K, Mouro I, Cherif-Zahar B, Raynal V, Cherrier C, et al. 1992. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc. Natl. Acad. Sci. USA 89:10925-29
25. Smith RE, Daleke DL. 1990. Phosphatidylserine transport in Rh null erythrocytes. Blood 76:1021-27
26. Morrot G, Zachowski A, Devaux PF. 1990. Partial purification and characterization of the human erythrocyte Mg2(+)-ATPase. A candidate aminophospholipid translocase. FEBS Lett. 266:29-32
27. Auland ME, Morris MB, Roufogalis BD. 1994. Separation and characterization of two Mg(2+)-ATPase activities from the human erythrocyte membrane. Arch. Biochem. Biophys. 312:272-77
28. Auland ME, Roufogalis BD, Devaux PF, Zachowski A. 1994. Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes. Proc. Natl. Acad. Sci. USA 91:10938-42
29. Daleke DL, Cornely-Moss K, Lyles J, Smith CM, Zimmerman M. 1992. Identification and characterization of a candidate phosphatidylserine- transporting AT-Pase. Ann. NY Acad. Sci. 671:468-70
30. Zimmerman ML, Daleke DL. 1993. Regulation of a candidate aminophospholipid-transporting ATPase by lipid. Biochemistry 32:12257-63
31. Zachowski A, Henry JP, Devaux PF. 1989. Control of transmembrane lipid asymmetry in chromaffin granules by an ATP-dependent protein. Nature 340:75-76
32. Tang X, Halleck MS, Schlegel RA, Williamson P. 1996. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science 272:1495-97
33. Gomes E, Jakobsen MK, Axelsen KB, Geisler M, Palmgren MG. 2000. Chilling tolerance in Arabidopsis involves ALA1, a member of a new family of putative aminophospholipid translocases. Plant Cell 12:2441-54
34. Siegmund A, Grant A, Angeletti C, Malone L, Nichols JW, Rudolph HK. 1998. Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae. J. Biol. Chem. 273:34399-405
35. Marx U, Polakowski T, Pomorski T, Lang C, Nelson H, et al. 1999. Rapid transbilayer movement of fluorescent phospholipid analogues in the plasma membrane of endocytosis-deficient yeast cells does not require the Drs2 protein. Eur. J. Biochem. 263:254-63
36. Gottesman MM, Pastan I. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385-427
37. Borst P, Zelcer N, van Helvoort A. 2000. ABC transporters in lipid transport. Biochim. Biophys. Acta 1486:128-44
38. Bitbol M, Devaux PF. 1988. Measurement of outward translocation of phospholipids across human erythrocyte membrane. Proc. Natl. Acad. Sci. USA 85:6783-87
39. Connor J, Pak CH, Zwaal RF, Schroit AJ. 1992. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process. J. Biol. Chem. 267:19412-17
40. Kamp D, Haest CW. 1998. Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim. Biophys. Acta 1372:91-101
41. Dekkers DC, Comfurius P, Schroit AJ, Bevers EM, Zwaal RA. 1998. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: Outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37:14833-37
42. Ruetz S, Gros P. 1994. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77:1071-81
43. Smith AJ, Timmermans-Hereijgers JL, Roelofsen B, Wirtz KW, van Blitterswijk WJ, et al. 1994. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 354:263-66
44. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, et al. 2000. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2:399-406
45. 2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry 31:6355-60
46. 2+-dependent transbilayer movement of phospholipid. J. Biol. Chem. 271:17205-10
47. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. 1997. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J. Biol. Chem. 272:18240-44
48. Weiss HJ. 1994. Scott syndrome: a disorder of platelet coagulant activity. Semin. Hematol. 31:312-19
49. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. 1996. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87:1409-15
50. 2+-dependent transbilayer migration of membrane phospholipids. J. Clin. Invest. 99:2232-38
51. Zhao J, Zhou Q, Wiedmer T, Sims PJ. 1998. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J. Biol. Chem. 273:6603-6
52. Fadeel B, Gleiss B, Hogstrand K, Chandra J, Wiedmer T, et al. 1999. Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem. Biophys. Res. Commun. 266:504-11
53. Zhou Q, Zhao J, Al Zoghaibi F, Zhou A, Wiedmer T, et al. 2000. Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha. Blood 95:2593-99
54. Zhou Q, Zhao J, Wiedmer T, Sims PJ. 2002. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 99:4030-38
55. Gleiss B, Gogvadze V, Orrenius S, Fadeel B. 2002. Fas-triggered phosphatidylserine exposure is modulated by intracellular ATP. FEBS Lett. 519:153-58
56. Sims PJ, Wiedmer T. 2001. Unraveling the mysteries of phospholipid scrambling. Throm. Haemost. 86:266-75
57. Brooks MB, Catalfamo JL, Brown HA, Ivanova P, Lovaglio J. 2002. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood 99:2434-41
58. Lelong I, Frechard E, Cremel G, Langley K, Rebel G, et al. 1991. Expression of plasma membrane and cell surface phospholipids and gangliosides of chick embryo neurons grown in primary cultures: developmental studies. Dev. Neurosci. 13:54-60
59. Ikemoto A, Kobayashi T, Emoto K, Umeda M, Watanabe S, Okuyama H. 1999. Effects of docosahexaenoic and arachidonic acids on the synthesis and distribution of aminophospholipids during neuronal differentiation of PC12 cells. Arch. Biochem. Biophys. 364:67-74
60. Emoto K, Kobayashi T, Yamaji A, Aizawa H, Yahara I, et al. 1996. Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc. Natl. Acad. Sci. USA 93:12867-72
61. Emoto K, Umeda M. 2000. An essential role for a membrane lipid in cytokinesis. Regulation of contractile ring disassembly by redistribution of phosphatidylethanolamine. J. Cell Biol. 149: 1215-24
62. Sessions A, Horwitz AF. 1983. Differentiation-related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells. Biochim. Biophys. Acta 728:103-11
63. van den Eijnde SM, Boshart L, Reutelingsperger CPM, De Zeeuw CI, Vermeij-Keers C. 1997. Phosphatidylderine plasma membrane asymmerty in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Differ. 4: 311-16
64. van den Eijnde SM, van den Hoff MJ, Reutelingsperger CP, van Heerde WL, Henfling ME, et al. 2001. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci. 114:3631-42
65. Kinnunen PK, Holopainen JM. 2000. Mechanisms of initiation of membrane fusion: role of lipids. Biosci. Rep. 20:465-82
66. Dillon SR, Constantinescu A, Schlissel MS. 2001. Annexin V binds to positively selected B cells. J. Immunol. 166:58-71
67. Dillon SR, Mancini M, Rosen A, Schlissel MS. 2000. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J. Immunol. 164:1322-32
68. Martin S, Pombo I, Poncet P, David B, Arock M, Blank U. 2000. Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int. Arch. Allergy Immunol. 123:249-58
69. Skutelsky E, Danon D. 1967. An electron microscopic study of nuclear elimination from the late erythroblast. J. Cell Biol. 33:625-35
70. Schlegel RA, Phelps BM, Cofer GP, Williamson P. 1982. Enucleation eliminates a differentiation-specific surface marker from normal and leukemic murine erythroid cells. Exp. Cell Res. 139:321-28
71. Connor J, Bucana C, Fidler IJ, Schroit AJ. 1989. Differentiation- dependent expression of phosphatidylserine in mammalian plasma membranes: quantitative assessment of outer-leaflet lipid by prothrombinase complex formation. Proc. Natl. Acad. Sci. USA 86:3184-88
72. Bevers EM, Comfurius P, Zwaal RF. 1983. Changes in membrane phospholipid distribution during platelet activation. Biochim. Biophys. Acta 736:57-66
73. Rosing J, Speijer H, Zwaal RF. 1988. Prothrombin activation on phospholipid membranes with positive electrostatic potential. Biochemistry 27:8-11
74. Esmon CT. 1993. Cell mediated events that control blood coagulation and vascular injury. Annu. Rev. Cell Biol. 9:1-26
75. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. 1991. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 77: 2641-48
76. Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenabeele P, Fiers W. 1997. Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 410:96-106
77. Salvesen GS, Dixit VM. 1997. Caspases: intracellular signaling by proteolysis. Cell 91:443-46
78. Green DR. 1998. Apoptotic pathways: the roads to ruin. Cell 94:695-98
79. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9
80. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207-16
81. Savill J, Fadok V, Henson P, Haslett C. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14:131-36
82. Verhoven B, Schlegel RA, Williamson P. 1995. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182:1597-601
83. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, et al. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545-56
84. Callahan MK, Williamson P, Schlegel RA. 2000. Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ. 7:645-53
85. Chang MK, Bergmark C, Laurila A, Horkko S, Han KH, et al. 1999. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA 96:6353-58
86. Balasubramanian K, Bevers EM, Willems GM, Schroit AJ. 2001. Binding of annexin v to membrane products of lipid peroxidation. Biochemistry 40:8672-76
87. Kagan VE, Fabisiak JP, Shvedova AA, Tyurina YY, Tyurin VA, et al. 2000. Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett. 477:1-7
88. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, et al. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274-77
89. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-51
90. Buttke TM, Sandstrom PA. 1994. Oxidative stress as a mediator of apoptosis Immunol. Today 15:7-10
91. Park SA, Choi KS, Bang JH, Huh K, Kim SU. 2000. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J. Neurochem. 75:946-53
92. Aluigi MG, De Flora S, D'Agostini F, Albini A, Fassina G. 2000. Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin. Anticancer Res. 20:3183-87
93. Horkko S, Bird DA, Miller E, Itabe H, Leitinger N, et al. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103:117-28
94. Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, et al. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10:325-35
95. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL. 1991. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87:90-99
96. Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA. 1989. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J. Biol. Chem. 264: 16957-62
97. Terpstra V, Bird DA, Steinberg D. 1998. Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. Proc. Natl. Acad. Sci. USA 95:1806-11
98. Sambrano GR, Terpstra V, Steinberg D. 1997. Independent mechanisms for macrophage binding and macrophage phagocytosis of damaged erythrocytes. Evidence of receptor cooperativity. Arterioscler. Thromb. Vasc. Biol. 17:3442-48
99. Bartosz G, Kedziora J, Retelewska W. 1991. Decreased oxidant-induced proteolysis in erythrocytes with enhanced antioxidative defence enzymes due to Down's syndrome. Clin. Chim. Acta 198: 239-43
100. Piomelli S, Seaman C. 1993. Mechanism of red blood cell aging: relationship of cell density and cell age. Am. J. Hematol. 42:46-52
101. Shukla SD, Hanahan DJ. 1982. Membrane alterations in cellular aging: susceptibility of phospholipids in density (age)-separated human erythrocytes to phospholipase A2. Arch. Biochem. Biophys. 214:335-41
102. Connor J, Pak CC, Schroit AJ. 1994. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J. Biol. Chem. 269:2399-404
103. Boas FE, Forman L, Beutler E. 1998. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc. Natl. Acad. Sci. USA 95: 3077-81
104. de Jong K, Beleznay Z, Ott P. 1996. Phospholipid asymmetry in red blood cells and spectrin-free vesicles during prolonged storage. Biochim. Biophys. Acta 1281:101-10
105. Herrmann A, Devaux PF. 1990. Alteration of the aminophospholipid translocase activity during in vivo and artificial aging of human erythrocytes. Biochim. Biophys. Acta 1027:41-46
106. Kiefer CR, Snyder LM. 2000. Oxidation and erythrocyte senescence. Curr. Opin. Hematol. 7:113-16
107. Tang TK. 1997. Free radical theory of erythrocyte aging. J. Formas. Med. Assoc. 96:779-83
108. Fabisiak JP, Tyurina YY, Tyurin VA, Lazo JS, Kagan VE. 1998. Random versus selective membrane phospholipid oxidation in apoptosis - role of phosphatidylserine. Biochemistry 37:13781-90
109. Jain SK. 1984. The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J. Biol. Chem. 259:3391-94
110. Walsh M, Lutz RJ, Cotter TG, O'Connor R. 2002. Erythrocyte survival is promoted by plasma and suppressed by a Bak-derived BH3 peptide that interacts with membrane-associated Bcl-X(L). Blood 99:3439-48
111. Mandal D, Moitra PK, Saha S, Basu J. 2002. Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett. 513:184-88
112. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, et al. 2001. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ. 8:1143-56
113. Middelkoop E, Lubin BH, Bevers EM, Op den Kamp JA, Comfurius P, et al. 1988. Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins. Biochim. Biophys. Acta 937:281-88
114. Tait JF, Gibson D. 1994. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J. Lab. Clin. Med. 123:741-48
115. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, et al. 1996. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 87:1179-87
116. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. 1993. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am. J. Hematol. 44:63-65
117. Kuypers FA, Yuan J, Lewis RA, Snyder LM, Kiefer CR, et al. 1998. Membrane phospholipid asymmetry in human thalassemia. Blood 91:3044-51
118. Wali RK, Jaffe S, Kumar D, Kalra VK. 1988. Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus. Diabetes 37:104-11
119. Wilson MJ, Richter-Lowney K, Daleke DL. 1993. Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes. Biochemistry 32:11302-10
120. Wang RH, Phillips G Jr, Medof ME, Mold C. 1993. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J. Clin. Invest. 92:1326-35
121. Liu C, Marshall P, Schreibman I, Vu A, Gai W, Whitlow M. 1999. Interaction between terminal complement proteins C5b-7 and anionic phospholipids. Blood 93:2297-301
122. Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ. 1985. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J. Clin. Invest. 75:1965-72
123. Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A. 1996. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia. Throm. Haemost. 76:322-27
124. Closse C, Dachary-Prigent J, Boisseau MR. 1999. Phosphatidylserine- related adhesion of human erythrocytes to vascular endothelium. Brt. J. Haematol. 107:300-2
125. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. 2000. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood 95:1293-300
126. Diaz C, Schroit AJ. 1996. Role of translocases in the generation of phosphatidylserine asymmetry. J. Membr. Biol. 151:1-9
127. Jain SK. 1989. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem. 264:21340-45
128. Rajeswari P, Natarajan R, Nadler JL, Kumar D, Kalra VK. 1991. Glucose induces lipid peroxidation and inactivation of membrane-associated ion-transport enzymes in human erythrocytes in vivo and in vitro. J. Cell Physiol. 149:100-9
129. Jain SK, Palmer M, Chen Y. 1999. Effect of vitamin E and N-acetylcysteine on phosphatidylserine externalization and induction of coagulation by high-glucose-treated human erythrocytes. Metabolism 48:957-59
130. Ravandi A, Kuksis A, Marai L, Myher JJ, Steiner G, et al. 1996. Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood. FEBS Lett. 381:77-81
131. Oak J, Nakagawa K, Miyazawa T. 2000. Synthetically prepared Aamadori-glycated phosphatidylethanolaminecan trigger lipid peroxidation via free radical reactions. FEBS Lett. 481:26-30
132. Esterbauer H, Schaur RJ, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128
133. Chandra J, Samali A, Orrenius S. 2000. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 29:323-33
134. Gouin-Thibault I, Achkar A, Samama MM. 2001. The thrombophilic state in cancer patients. Acta Haematol. 106:33-42
135. Gale AJ, Gordon SG. 2001. Update on tumor cell procoagulant factors. Acta Haematol. 106:25-32
136. Bucana CD, Hoyer LC, Schroit AJ, Kleinerman E, Fidler, IJ. 1983. Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro. Am. J. Pathol. 112:101-11
137. Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. 1991. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res. 51:3062-66
138. Rao LV, Tait JF, Hoang AD. 1992. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Throm. Res. 67:517-31
139. Sugimura M, Donato R, Kakkar VV, Scully MF. 1994. Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces. Blood Coagul. Fibrin. 5:365-73
140. Bombeli T, Karsan A, Tait JF, Harlan JM. 1997. Apoptotic vascular endothelial cells become procoagulant. Blood 89:2429-42
141. Bombeli T, Schwartz BR, Harlan JM. 1999. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 93:3831-38
142. Ran S, Gao BN, Duffy S, Watkins L, Rote N, Thorpe PE. 1998. Infarction of solid Hodgkins tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature. Cancer Res. 58:4646-53
143. Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR. 2000. Role of apoptosis in autoimmunity. Apoptosis 5:443-49
144. Casciola-Rosen L, Rosen, Petri M, Schlissel M. 1996. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93:1624-29
145. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, et al. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411:207-11
146. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, et al. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56-59
147. Reddien PW, Cameron S, Horvitz HR. 2001. Phagocytosis promotes programmed cell death in C. elegans. Nature 412: 198-202
148. Arends MJ, Wyllie AH. 1991. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32:223-54
149. Franc NC. 2002. Phagocytosis of apoptotic cells in mammals, Caenorhabditis elegans and Drosophila melanogaster: molecular mechanisms and physiological consequences. Front. Biosci. 7:D1298-313
150. Wyllie AH, Kerr JF, Currie AR. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306
151. Wu YC, Horvitz HR. 1998. The C. elegans cell corpse engulfment gene ced-7 encodes a protein similar to ABC transporters. Cell 93:951-60
152. Zhou Z, Hartwieg E, Horvitz HR. 2001. CED-1 is a transmembrane receptor that mediates cell corpse engulfment in C. elegans. Cell 104:43-56
153. Hengartner MO. 2001. Apoptosis: corralling the corpses. Cell 104:325-28
154. Su HP, Nakada-Tsukui K, Tosello-Trampont AC, Li Y, Bu G, et al. 2002. Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP). J. Biol. Chem. 277:11772-79
155. Liu QA, Hengartner MO. 1998. Candidate adaptor protein CED-6 promotes the engulfment of apoptotic cells in C. elegans. Cell 93:961-72
156. Marguet D, Luciani MF, Moynault A, Williamson P, Chimini G. 1999. Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey. Nat. Cell Biol. 1:454-56
157. Pearson A, Lux A, Krieger M. 1995. Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 92:4056-60
158. Franc NC, Heitzler P, Ezekowitz RA, White K. 1999. Requirement for croquemort in phagocytosis of apoptotic cells in Drosophila. Science 284:1991-94
159. Nakano T, Higashino K, Kikuchi N, Kishino J, Nomura K, et al. 1995. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J. Biol. Chem. 270:5702-5
160. Nakano T, Ishimoto Y, Kishino J, Umeda M, Inoue K, et al. 1997. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J. Biol. Chem. 272:29411-14
161. Ishimoto Y, Ohashi K, Mizuno K, Nakano T. 2000. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J. Biochem. 127:411-17
162. Varner JA, Cheresh DA. 1996. Integrins and cancer. Curr. Opin. Cell Biol. 8:724-30
163. Hynes RO. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
164. Ruoslahti E, Pierschbacher MD. 1986. Arg-Gly-Asp: a versatile cell recognition signal. Cell 44:517-18
165. Savill J, Dransfield I, Hogg N, Haslett C. 1990. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343:170-73
166. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, et al. 1992. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J. Immunol. 149:4029-35
167. Bornstein P. 2001. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107:929-34
168. Chen H, Herndon ME, Lawler J. 2000. The cell biology of thrombospondin-1. Matrix Biol. 19:597-614
169. Savill J, Hogg N, Ren Y, Haslett C. 1992. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1513-22
170. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, et al. 1998. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359-68
171. Schwartz BR, Karsan A, Bombeli T, Harlan JM. 1999. A novel beta 1 integrin-dependent mechanism of leukocyte adherence to apoptotic cells. J. Immunol. 162:4842-48
172. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. 2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 417:182-87
173. Stubbs JD, Lekutis C, Singer KL, Bui A, Yuzuki D, et al. 1990. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. Proc. Natl. Acad. Sci. USA 87:8417-21
174. Wilde CJ, Knight CH, Flint DJ. 1999. Control of milk secretion and apoptosis during mammary involution. J. Mammary Gland Biol. Neoplasia 4:129-36
175. Ulevitch RJ, Tobias PS. 1994. Recognition of endotoxin by cells leading to transmembrane signaling. Curr. Opin. Immunol. 6:125-30
176. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:547-52
177. Martin MA. 1991. Epidemiology and clinical impact of gram-negative sepsis. Infect. Dis. Clin. North Am. 5:739-52
178. Wang PY, Kitchens RL, Munford RS. 1998. Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J. Biol. Chem. 273: 24309-13
179. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons, DL, Gregory CD. 1998. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392:505-9
180. Schlegel RA, Krahling S, Callahan MK, Williamson P. 1999. CD14 is a component of multiple recognition systems used by macrophages to phagocytose apoptotic lymphocytes. Cell Death Differ. 6:583-92
181. Moffatt OD, Devitt A, Bell ED, Simmons DL, Gregory CD. 1999. Macrophage recognition of ICAM-3 on apoptotic leukocytes. J. Immunol. 162:6800-10
182. Fawcett J, Holness CL, Needham LA, Turley H, Gatter KC, et al. 1992. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 360:481-84
183. Klickstein LB, York MR, Fougerolles AR, Springer TA. 1996. Localization of the binding site on intercellular adhesion molecule-3 (ICAM-3) for lymphocyte function-associated antigen 1 (LFA-1). J. Biol. Chem 271:23920-27
184. Bell ED, May AP, Simmons DL. 1998. The leukocyte function-associated antigen-1 (LFA-1)-binding site on ICAM-3 comprises residues on both faces of the first immunoglobulin domain. J. Immunol. 161:1363-70
185. Van DV, Le Trong H, Wood CL, Moore PF, St John T, et al. 1995. A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity 3:683-90
186. Simmons DL. 1995. The role of ICAM expression in immunity and disease. Cancer Surv. 24:141-55
187. Muller-Eberhard HJ. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57: 321-47
188. Tsuji S, Kaji K, Nagasawa S. 1994. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. J. Biochem. 116:794-800
189. Mevorach D. 2000. Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Ann. NY Acad. Sci. 926:226-35
190. Huong TM, Ishida T, Harashima H, Kiwada H. 2001. The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig. Int. J. Pharm. 215:197-205
191. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. 1998. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188:2313-20
192. Takizawa F, Tsuji S, Nagasawa S. 1996. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. FEBS Lett. 397:269-72
193. Fishelson Z, Attali G, Mevorach D. 2001. Complement and apoptosis. Mol. Immunol. 38:207-19
194. Hansen S, Holmskov U. 1998. Structural aspects of collectins and receptors for collectins. Immunobiology 199:165-89
195. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, et al. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:781-95
196. Steinberger P, Szekeres A, Wille S, Stockl J, Selenko N, et al. 2002. Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning. J. Leukoc. Biol. 71:133-40
197. Robson MG, Cook HT, Botto M, Taylor PR, Busso N, et al. 2001. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J. Immunol. 166:6820-28
198. Wurm H. 1984. beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int. J. Biochem. 16:511-15
199. Chonn A, Semple SC, Cullis PR. 1995. Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J. Biol. Chem. 270:25845-49
200. Balasubramanian K, Chandra J, Schroit AJ. 1997. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J. Biol. Chem. 272:31113-17
201. Balasubramanian K, Schroit AJ. 1998. Characterization of phosphatidylserine-dependent beta(2)-glycoprotein I macrophage interactions - implications for apoptotic cell clearance by phagocytes. J. Biol. Chem. 273:29272-77
202. Lee AT, Balasubramanian K, Schroit AJ. 2000. beta(2)-glycoprotein I-dependent alterations in membrane properties. Biochim. Biophys. Acta 1509:475-84
203. Wang SX, Cai GP, Sui SF. 1999. Intrinsic fluorescence study of the interaction of human apolipoprotein H with phospholipid vesicles. Biochemistry 38:9477-84
204. Shirai H, Murakami T, Yamada Y, Doi T, Hamakubo T, Kodama T. 1999. Structure and function of type I and II macrophage scavenger receptors. Mech. Ageing Dev. 111:107-21
205. Emi M, Asaoka H, Matsumoto A, Itakura H, Kurihara Y, et al. 1993. Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J. Biol. Chem. 268:2120-25
206. Naito M, Kodama T, Matsumoto A, Doi T, Takahashi K. 1991. Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. Am. J. Pathol. 139:1411-23
207. Mato M, Ookawara S, Sakamoto A, Aikawa E, Ogawa T, et al. 1996. Involvement of specific macrophage-lineage cells surrounding arterioles in barrier and scavenger function in brain cortex. Proc. Natl. Acad. Sci. USA 93:3269-74
208. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, et al. 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292-96
209. Haworth R, Platt N, Keshav S, Hughes D, Darley E, et al. 1997. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J. Exp. Med. 186:1431-39
210. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S. 1996. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. USA 93:12456-60
211. Platt N, da Silva RP, Gordon S. 1998. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol. 8:365-72
212. Terpstra V, van Berkel TJ. 2000. Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 95:2157-63
213. Platt N, Suzuki H, Kodama T, Gordon S. 2000. Apoptotic thymocyte clearance in scavenger receptor class A-deficient mice is apparently normal. J. Immunol. 164:4861-67
214. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, et al. 1995. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 80:603-9
215. van der Laan LJ, Dopp EA, Haworth R, Pikkarainen T, Kangas M, et al. 1999. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J. Immunol. 162:939-47
216. Kraal G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31-74
217. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-20
218. Calvo D, Vega MA. 1993. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/ LIMPII gene family. J. Biol. Chem 268: 18929-35
219. Ji Y, Jian B, Wang N, Sun Y, Moya ML, et al. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem 272:20982-85
220. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. 1997. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387:414-17
221. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, et al. 2000. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105:1049-56
222. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RG, et al. 1997. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem. 272:13242-49
223. Fielding PE, Fielding CJ. 1995. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34:14288-92
224. Fadok VA, Warner ML, Bratton DL, Henson PM. 1998. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol. 161:6250-57
225. Matveev S, van der Westhuyzen DR, Smart EJ. 1999. Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J. Lipid Res. 40:1647-54
226. Puyraimond A, Fridman R, Lemesle M, Arbeille B, Menashi S. 2001. MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp. Cell Res. 262:28-36
227. Tait JF, Smith C. 1999. Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells. J. Biol. Chem. 274:3048-54
228. Nakamura K, Funakoshi H, Miyamoto K, Tokunaga F, Nakamura T. 2001. Molecular cloning and functional characterization of a human scavenger receptor with C-type lectin (SRCL), a novel member of a scavenger receptor family. Biochem. Biophys. Res. Commun. 280:1028-35
229. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, et al. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73-77
230. Oka K, Sawamura T, Kikuta K, Itokawa S, Kume N, et al. 1998. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc. Natl. Acad. Sci. USA 95:9535-40
231. Shimaoka T, Kume N, Minami M, Hayashida K, Sawamura T, et al. 2001. LOX-1 supports adhesion of gram-positive and gram-negative bacteria. J. Immunol. 166:5108-14
232. Rabinowitz SS, Gordon S. 1991. Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J. Exp. Med. 174:827-36
233. Holness CL, da Silva RP, Fawcett J, Gordon S, Simmons DL. 1993. Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. J. Biol. Chem. 268:9661-66
234. da Silva RP, Platt N, de Villiers JS, Gordon S. 1996. Membrane molecules and macrophage endocytosis: scavenger receptor and macrosialin as markers of plasma-membrane and vacuolar functions. Biochem. Soc. Trans. 24:220-24
235. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. 1995. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc. Natl. Acad. Sci. USA 92:9580-84
236. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. 1996. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 93:14833-38
237. Van Velzen AG, da Silva RP, Gordon S, van Berkel TJ. 1997. Characterization of a receptor for oxidized low-density lipoproteins on rat Kupffer cells: similarity to macrosialin. Biochem. J. 322:411-15
238. Adachi H, Tsujimoto M, Arai H, Inoue K. 1997. Expression cloning of a novel scavenger receptor from human endothelial cells. J. Biol. Chem. 272:31217-20
239. Shimaoka T, Kume N, Minami M, Hayashida K, Kataoka H, et al. 2000. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J. Biol. Chem. 275:40663-66
240. Minami M, Kume N, Shimaoka T, Kataoka H, Hayashida K, et al. 2001. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 21:1796-800
241. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RB, Henson PM. 2000. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85-90
242. Hoffmann PR, de Cathelineau AM, Ogden CA, Leverrier Y, Bratton DL, et al. 2001. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155:649-59
243. Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL. 2001. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 276:1071-77
244. Albert ML, Sauter B, Bhardwaj N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89
245. Krahling S, Callahan MK, Williamson P, Schlehel RA. 1999. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 6:183-89
246. Chang GH, Barbaro NM, Pieper RO. 2000. Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells. Neuro-Oncology 2:174-83
247. Hu B, Sonstein J, Christensen PJ, Punturieri A, Curtis JL. 2000. Deficient in vitro and in vivo phagocytosis of apoptotic T cells by resident murine alveolar macrophages. J. Immunol. 165:2124-33
248. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101:890-98
249. McDonald PP, Fadok VA, Bratton D, Henson PM. 1999. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells. J. Immunol. 163:6164-72
250. Henson PM, Bratton DL, Fadok VA. 2001. The phosphatidylserine receptor: a crucial molecular switch? Nat. Rev. Mol. Cell Biol. 2:627-33
251. Huynh ML, Fadok VA, Henson PM. 2002. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109:41-50
252. Pike LJ, Han X, Chung KN, Gross RW. 2002. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41:2075-88
253. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. 2000. Role of CD47 as a marker of self on red blood cells. Science 288:2051-54
254. Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, Savill J. 2002. Apoptosis disables CD31-mediated cell detachment from phagocytosis promoting binding and engulfment. Nature 418:200-3
255. Ayllon V, Fleischer A, Cayla X, Garcia A, Rebollo A. 2002. Segregation of Bad from lipid rafts is implicated in the induction of apoptosis. J. Immunol. 168:3387-93
256. Zwaal RF, Bevers EM, Comfurius P, Rosing T, Tilly RH, Verhallen PF. 1989. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol. Cell Biochem. 91:23-31